ALZHEIMER DISEASE (AD)
Clinical trials for ALZHEIMER DISEASE (AD) explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMER DISEASE (AD) trials appear
Sign up with your email to follow new studies for ALZHEIMER DISEASE (AD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Soy extract tested to slow memory loss in early Alzheimer's
Disease control Not yet recruitingThis study will test whether a natural compound called genistein, found in soy, can slow down memory and thinking problems in people with early Alzheimer's disease. About 150 participants with mild cognitive impairment will take either the genistein extract or a placebo daily for…
Matched conditions: ALZHEIMER DISEASE (AD)
Phase: NA • Sponsor: Universidad Católica San Antonio de Murcia • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Brain scan study aims to personalize Alzheimer's treatment
Disease control Not yet recruitingThis study is testing whether the antibody drug lecanemab helps control Alzheimer's disease progression better than standard treatments. Researchers will follow 120 patients with early Alzheimer's or mild cognitive impairment to see who benefits most from continued treatment. Usi…
Matched conditions: ALZHEIMER DISEASE (AD)
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Gut-Brain link: new hope for slowing Alzheimer's?
Disease control Not yet recruitingThis study is testing if a supplement called tributyrin can help slow memory and thinking problems in people with mild Alzheimer's disease. Researchers believe tributyrin may work by improving gut health and reducing brain inflammation. About 156 participants will take either the…
Matched conditions: ALZHEIMER DISEASE (AD)
Phase: PHASE3 • Sponsor: Universidad de Almeria • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Cutting Alzheimer's diagnosis wait from 533 days to 195
Diagnosis Not yet recruitingThis study aims to make diagnosing Alzheimer's disease faster and more accessible. It will test a nurse-led screening tool to identify eligible patients for new blood tests and brain scans, bypassing long waits for specialist appointments. The goal is to reduce the time to diagno…
Matched conditions: ALZHEIMER DISEASE (AD)
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC
-
AI could replace second brain scan for Alzheimer's patients
Diagnosis Not yet recruitingThis study tests whether artificial intelligence (AI) can create one type of brain scan image from another, using existing patient data. Currently, diagnosing Alzheimer's often requires two separate scans. If successful, this AI method could reduce radiation exposure, costs, and …
Matched conditions: ALZHEIMER DISEASE (AD)
Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Mar 16, 2026 15:24 UTC
-
Groundbreaking Dual-Target Alzheimer's vaccine enters human testing
Prevention Not yet recruitingThis early-stage study will test the safety of an experimental Alzheimer's vaccine called DUVAX in 24 healthy adults aged 40-65. Participants will receive either the vaccine or a placebo injection to see how well it's tolerated and whether it triggers an immune response against A…
Matched conditions: ALZHEIMER DISEASE (AD)
Phase: PHASE1 • Sponsor: Nuravax, Inc. • Aim: Prevention
Last updated Mar 23, 2026 15:15 UTC
-
Study investigates hidden toll on Alzheimer's caregivers
Knowledge-focused Not yet recruitingThis study aims to understand the experiences of family members who care for people with Alzheimer's disease, both during caregiving and after the patient's death. Researchers will interview 66 caregivers and use questionnaires to measure how caregiving affects their emotional we…
Matched conditions: ALZHEIMER DISEASE (AD)
Sponsor: Universidad Rey Juan Carlos • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC